Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-22-002379
Filing Date
2022-02-03
Accepted
2022-02-03 16:31:16
Documents
1
Period of Report
2022-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1952
  Complete submission text file 0001437749-22-002379.txt   3294
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2420 17TH STREET SUITE 220 DENVER CO 80202
Business Address
Garlikov Julie (Reporting) CIK: 0001793266 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33678 | Film No.: 22588885